TREATMENT OF ASTHMA AND AIRWAY DISEASES
    2.
    发明申请
    TREATMENT OF ASTHMA AND AIRWAY DISEASES 审中-公开
    治疗哮喘和气道疾病

    公开(公告)号:WO1997042958A1

    公开(公告)日:1997-11-20

    申请号:PCT/AU1997000286

    申请日:1997-05-09

    CPC classification number: A61K31/566 A61K31/565 Y10S514/826

    Abstract: The invention relates to use of steroids or steroid analogues in the treatment of chronic and acute inflammation of the airways, particularly asthmatic conditions. It also relates to compounds and compositions which modulate airway remodelling. In a preferred embodiment, the steroid is 2-methoxyoestradiol.

    Abstract translation: 本发明涉及类固醇或类固醇类似物在治疗气道的慢性和急性炎症,特别是哮喘病症中的应用。 它还涉及调节气道重塑的化合物和组合物。 在优选的实施方案中,类固醇是2-甲氧基雌二醇。

    ESTRATRIENE DERIVATIVES
    4.
    发明申请
    ESTRATRIENE DERIVATIVES 审中-公开
    ESTRATRIENE衍生物

    公开(公告)号:WO2004101595A1

    公开(公告)日:2004-11-25

    申请号:PCT/AU2004/000630

    申请日:2004-05-13

    CPC classification number: C07J41/00 C07J43/00 Y02P20/582

    Abstract: Compounds and methods for modulating mesenchymal cell function, for instance smooth muscle and fibroblast proliferation or cytokine expression, and for treating conditions associated with mesenchymal cell function, for instance airway hyperresponsiveness associated with asthma. The compounds also supress inflammation. The compounds are a class of estratriene derivates, and includes various derivatives of 2-methoxyestradiol comprising a group A, including a substituted aromatic substituent in the 2-, 6- or 17- position.

    Abstract translation: 用于调节间充质细胞功能的化合物和方法,例如平滑肌和成纤维细胞增殖或细胞因子表达,以及用于治疗与间充质细胞功能相关的病症,例如与哮喘相关的气道高反应性。 这些化合物也能抑制炎症。 该化合物是一类雌三烯衍生物,并且包括包含A组的2-甲氧基雌二醇的各种衍生物,包括在2-,6-或17-位的取代的芳族取代基。

Patent Agency Ranking